World's Best Scientists 2026 revealed!
Award Badge
Immunology
USA
2026

D-Index & Metrics

Immunology

D-Index
156
Citations
107851
World Ranking
97
National Ranking
61

Medicine

D-Index
156
Citations
107957
World Ranking
907
National Ranking
513

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Immunology in United States Leader Award

Overview

Ralph S. Baric is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research focuses primarily on Medicine, with extensive work in Infectious Diseases, Animal Science and Zoology, Epidemiology, Molecular Biology, and Immunology.

The scientist's main topics of research include:

  • SARS-CoV-2 and COVID-19 Research
  • Animal Virus Infections Studies
  • Viral gastroenteritis research and epidemiology
  • COVID-19 Clinical Research Studies
  • Respiratory viral infections research
  • Mosquito-borne diseases and control
  • Virus-based gene therapy research

Frequent co-authors working alongside Ralph S. Baric include:

  • Sarah R. Leist
  • Alexandra Schäfer
  • Boyd L. Yount
  • David R. Martinez
  • Timothy P. Sheahan

Their research is often published in venues such as UNC Libraries, bioRxiv (Cold Spring Harbor Laboratory), Science Translational Medicine, Nature Communications, and Nature.

Notable recent papers are:

  • "The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2" (2020), Nature Microbiology
  • "Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus" (2020), Journal of Virology
  • "Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity" (2020), Cell
  • "Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV" (2020), Nature Communications
  • "SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract" (2020), Cell

Best Publications

  • The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

    Alexander E. Gorbalenya;Susan C. Baker;Ralph S. Baric;Raoul J. de Groot

  • Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.

    Yushun Wan;Jian Shang;Rachel Graham;Ralph S. Baric

  • Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking

    Mingxun Wang;Jeremy J Carver;Vanessa V Phelan;Laura M Sanchez

  • Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.

    Timothy P. Sheahan;Amy C. Sims;Sarah R. Leist;Alexandra Schäfer

  • Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group

    Alexander E. Gorbalenya;Alexander E. Gorbalenya;Susan C. Baker;Ralph Baric;Raoul J. de Groot

  • Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.

    Carolyn Rydyznski Moderbacher;Sydney I. Ramirez;Sydney I. Ramirez;Jennifer M. Dan;Jennifer M. Dan;Alba Grifoni

  • Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

    Timothy P. Sheahan;Amy C. Sims;Rachel L. Graham;Vineet D. Menachery

  • SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.

    Yixuan J. Hou;Kenichi Okuda;Caitlin E. Edwards;David R. Martinez

  • SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.

    Kizzmekia S. Corbett;Darin K. Edwards;Sarah R. Leist;Olubukola M. Abiona

  • Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.

    Raoul J. de Groot;Susan C. Baker;Ralph S. Baric;Caroline S. Brown

  • Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.

    Evan J. Anderson;Nadine G. Rouphael;Alicia T. Widge;Lisa A. Jackson

  • Norwalk Virus: How Infectious Is It?

    Peter F.M. Teunis;Christine L. Moe;Pengbo Liu;Sara E. Miller

  • Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

    Maria L. Agostini;Erica L. Andres;Amy C Sims;Rachel Lauren Graham

  • Human susceptibility and resistance to Norwalk virus infection

    Lisa Lindesmith;Christine Moe;Severine Marionneau;Nathalie Ruvoen

  • Potently neutralizing and protective human antibodies against SARS-CoV-2.

    Seth J. Zost;Pavlo Gilchuk;James Brett Case;Elad Binshtein

  • A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence

    Vineet D. Menachery;Boyd L. Yount;Kari Debbink;Sudhakar Agnihothram

  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.

    Kizzmekia S Corbett;Barbara Flynn;Kathryn E Foulds;Joseph R Francica

  • An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.

    Timothy P. Sheahan;Amy C. Sims;Shuntai Zhou;Rachel L. Graham

  • DNA vaccine protection against SARS-CoV-2 in rhesus macaques.

    Jingyou Yu;Lisa H. Tostanoski;Lauren Peter;Noe B. Mercado

  • Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture

    Aartjan J. W. te Velthuis;Sjoerd H. E. van den Worm;Amy C. Sims;Ralph S. Baric

Frequent Co-Authors

Boyd Yount
Boyd Yount University of North Carolina at Chapel Hill
Lisa E. Gralinski
Lisa E. Gralinski University of North Carolina at Chapel Hill
Vineet D. Menachery
Vineet D. Menachery The University of Texas Medical Branch at Galveston
Amy C. Sims
Amy C. Sims University of North Carolina at Chapel Hill
Eric F. Donaldson
Eric F. Donaldson Center for Drug Evaluation and Research
Timothy P. Sheahan
Timothy P. Sheahan University of North Carolina at Chapel Hill
Alexandra Schäfer
Alexandra Schäfer Duke University
Mark T. Heise
Mark T. Heise University of North Carolina at Chapel Hill
David R. Martinez
David R. Martinez Yale University
Mark R. Denison
Mark R. Denison Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your qualifications in healthcare can open diverse career pathways. Many students pursue nursing degrees online to build a strong clinical foundation. Accelerated options are especially popular for those with prior experience in related fields.

Programs like the nurse practitioner accelerated program offer a fast track to advanced practice roles, combining rigorous coursework with hands-on training. These programs prepare graduates for roles that intersect closely with immunological research and patient care.

For individuals without a nursing background, the 12-month accelerated nursing programs online for non nurses provide an efficient pathway to enter the nursing field. The accelerated format allows for quicker transition into immunology-related clinical roles.

Students seeking accessible nursing programs can explore the easiest accelerated nursing programs or even lpn schools easy to get into. These programs emphasize streamlined admissions and practical training, providing foundational skills relevant to immunology careers in healthcare settings.

Best Scientists Citing Ralph S. Baric

Trending Scientists

Recently Published Articles